Chapter 9 Mechanisms of Enzyme Catalysis, Inhibition, and Chymotrypsin Proteolysis

Catalytic Strategies of Enzymes

• Fundamental Catalytic Principle:

  • Enzymes catalyze an enormous variety of biochemical transformations by selectively stabilizing the transition state of the reaction, thereby lowering the free energy of activation ($\Delta G^\ddagger$).

  • Maximal binding energy is achieved when an enzyme engages the substrate in its transition-state conformation, driving catalysis.

• Covalent Catalysis:

  • The enzyme active site contains a potent reactive group, typically a strong nucleophile, that undergoes temporary covalent modification during the reaction sequence.

  • Nucleophile Definition: An electron-rich chemical group or atom attracted to centers of positive charge that reacts by donating an electron pair to an electrophile.

  • Electrophile Definition: An electron-deficient chemical species attracted to regions of negative charge that reacts by accepting an electron pair from a nucleophile.

• General Acid–Base Catalysis:

  • A reactive molecule other than water serves as a proton donor (general acid) or proton acceptor (general base).

  • In chymotrypsin, a specific histidine residue ($\text{His } 57$) acts as a general base to extract a proton from a serine residue ($\text{Ser } 195$), markedly enhancing its nucleophilic reactivity.

• Metal Ion Catalysis:

  • Bound metal cations participate directly in enzyme catalysis through several distinct mechanisms:

  • Acting as electrophilic catalysts to stabilize transient negative charges on reaction intermediates.

  • Generating potent nucleophiles at physiological $\text{pH}$ by increasing the acidity of adjacent coordinated molecules, such as water.

  • Binding directly to substrate molecules to increase the total number of noncovalent interactions with the active site, thereby enhancing binding energy.

  • Serving as essential structural or catalytic cofactors across numerous enzyme classes.

• Catalysis by Approximation:

  • Reactions involving two or more distinct substrates are accelerated by binding both reactants onto a single enzyme surface in close spatial proximity and oriented in the precise geometry required for reaction.

Environmental Modulation of Enzyme Activity: Temperature and pH

• Thermal Enhancement and Denaturation:

  • Reaction velocity increases as temperature rises because higher thermal energy accelerates Brownian motion, increasing collision frequency between enzyme active sites and substrate molecules.

  • Each enzyme displays an optimal temperature beyond which catalytic activity precipitously drops due to thermal denaturation: the noncovalent interactions maintaining native tertiary and quaternary protein structure are disrupted by excessive thermal motion.

• Biological Adaptations to Temperature:

  • Endotherms: Organisms that maintain homeostatic internal temperatures (such as humans) minimize the physiological impact of ambient thermal fluctuations on enzymatic velocity. Mild localized temperature increases—such as the muscle warming experienced by athletes during physical exertion—accelerate metabolic biochemistry.

  • Ectotherms: Organisms whose body temperatures equilibrate with the ambient environment (such as lizards) depend directly on external temperature to regulate enzymatic and physical activity.

  • Thermophilic Organisms: Specialized organisms such as thermophilic archaea thrive at temperatures of $80\,^\circ\text{C}$ or above, possessing enzymes stabilized by evolutionary adaptations that confer extreme resistance to thermal denaturation.

• pH Dependence of Catalytic Rates:

  • Enzyme activity varies as a function of environmental hydronium ion concentration ($[\text{H}^+]$), typically producing a bell-shaped activity curve.

  • The optimal $\text{pH}$ directly reflects the specific biological and physiological niche of each enzyme:

  • Pepsin, an acid-tolerant digestive protease operating in gastric juice, exhibits an optimal $\text{pH}$ range of $1\text{--}2$.

  • Chymotrypsin, secreted by the pancreas into the neutral-to-alkaline environment of the upper small intestine, displays maximal activity near $\text{pH } 8$.

• Ionization States of Catalytic R Groups:

  • The bell-shaped response to $\text{pH}$ is governed by the ionization state of critical amino acid side chains within the active site.

  • For example, in an active site requiring both a deprotonated carboxylate ($-\text{COO}^-$ from glutamic acid or aspartate) and a protonated amino group ($-\text{NH}_3^+$ from lysine):

  • At low $\text{pH}$, excess protons convert active $-\text{COO}^-$ groups to uncharged $-\text{COOH}$, abolishing catalytic competence.

  • At high $\text{pH}$, basic hydroxide ions abstract protons from $-\text{NH}_3^+$ to yield neutral $-\text{NH}_2$, likewise eliminating activity.

Reversible Enzyme Inhibition: Mechanisms and Kinetic Signatures

• Characteristics of Reversible Inhibition:

  • Reversible inhibitors associate with enzymes through noncovalent interactions and exist in rapid equilibrium with the target enzyme, permitting dissociation of the enzyme–inhibitor complex.

  • Reversible inhibitors are divided into competitive, uncompetitive, and noncompetitive classes based on binding location and kinetic effects.

• Competitive Inhibition:

  • Binding Mechanism: The inhibitor resembles the substrate and competes directly for the unoccupied active site. The enzyme binds either substrate ($\text{ES}$) or inhibitor ($\text{EI}$), but never both simultaneously ($\text{ESI}$ does not form).

  • Kinetic Impact: Catalytic rate is diminished at low substrate levels by decreasing the proportion of active sites occupied by substrate. High substrate concentrations outcompete the inhibitor, meaning maximal velocity ($V_{\max}$) is unchanged while the apparent Michaelis constant ($K_M^{\text{app}}$) is increased:     $K_M^{\text{app}} = K_M \left(1 + \frac{[\text{I}]}{K_i}\right)$

• Uncompetitive Inhibition:

  • Binding Mechanism: The inhibitor binds exclusively to the preformed enzyme–substrate complex ($\text{ES}$). The inhibitor binding site is created only upon substrate engagement, making this form of inhibition strictly substrate-dependent.

  • Kinetic Impact: The dead-end $\text{ESI}$ complex cannot form product. Increasing substrate concentration cannot overcome uncompetitive inhibition. Both the apparent maximal velocity ($V_{\max}^{\text{app}}$) and apparent Michaelis constant ($K_M^{\text{app}}$) decrease by the identical proportionality factor ($\alpha'$):     $V_{\max}^{\text{app}} = \frac{V_{\max}}{\alpha'}, \quad K_M^{\text{app}} = \frac{K_M}{\alpha'}, \quad \text{where } \alpha' = 1 + \frac{[\text{I}]}{K_i'}$

• Noncompetitive Inhibition (Pure and Mixed):

  • Pure Noncompetitive Inhibition Mechanism: The inhibitor binds reversibly to an allosteric site on both free enzyme ($\text{E}$) and enzyme–substrate complex ($\text{ES}$) with identical dissociation constants ($K_i = K_i'$). Substrate and inhibitor bind simultaneously without mutual interference.

  • Pure Noncompetitive Kinetics: Substrate binding affinity is unaffected ($K_M$ remains constant), but catalytic turnover ($k_{\text{cat}}$) is suppressed, lowering apparent maximal velocity ($V_{\max}^{\text{app}}$). High substrate concentrations cannot rescue activity.

  • Mixed Noncompetitive Inhibition: The inhibitor displays unequal affinity for free enzyme ($\text{E}$) versus enzyme–substrate complex ($\text{ES}$). Consequently, $V_{\max}$ always decreases, while $K_M^{\text{app}}$ either increases or decreases depending on whether the inhibitor binds preferentially to $\text{E}$ or $\text{ES}$.

• Double-Reciprocal (Lineweaver–Burk) Analysis:

  • Expressed via the linearized equation:     $\frac{1}{V_0} = \left( \frac{K_M}{V_{\max}} \right) \frac{1}{[\text{S}]} + \frac{1}{V_{\max}}$

  • Competitive Plots: Lines for inhibited and uninhibited enzymes intersect on the y-axis at identical values ($1/V_{\max}$ is unchanged). The slope ($K_M/V_{\max}$) increases, and the x-intercept ($-1/K_M^{\text{app}}$) shifts closer to the origin.

  • Uncompetitive Plots: Parallel lines with identical slopes ($K_M/V_{\max}$). The y-intercept ($1/V_{\max}^{\text{app}}$) increases, and the x-intercept ($-1/K_M^{\text{app}}$) shifts farther to the left (becomes more negative).

  • Pure Noncompetitive Plots: Lines intersect directly on the x-axis ($-1/K_M$ is identical). The y-intercept ($1/V_{\max}^{\text{app}}$) and slope increase by the exact same proportion.

• Quantitative Evaluation of Experimental Inhibition Data:

  • Raw Kinetic Data:

  • At $[\text{S}] = 3\,\mu\text{M}$: $V_0 (\text{control}) = 10.4\,\mu\text{mol/min}$; $V_0 (+\text{inhibitor}) = 2.1\,\mu\text{mol/min}$

  • At $[\text{S}] = 5\,\mu\text{M}$: $V_0 (\text{control}) = 14.5\,\mu\text{mol/min}$; $V_0 (+\text{inhibitor}) = 2.9\,\mu\text{mol/min}$

  • At $[\text{S}] = 10\,\mu\text{M}$: $V_0 (\text{control}) = 22.5\,\mu\text{mol/min}$; $V_0 (+\text{inhibitor}) = 4.5\,\mu\text{mol/min}$

  • At $[\text{S}] = 30\,\mu\text{M}$: $V_0 (\text{control}) = 33.8\,\mu\text{mol/min}$; $V_0 (+\text{inhibitor}) = 6.8\,\mu\text{mol/min}$

  • At $[\text{S}] = 90\,\mu\text{M}$: $V_0 (\text{control}) = 40.5\,\mu\text{mol/min}$; $V_0 (+\text{inhibitor}) = 8.1\,\mu\text{mol/min}$

  • Reciprocal Transformed Data ($1/[\text{S}]$ vs $1/V_0$):

  • $1/[\text{S}] = 0.333\,\mu\text{M}^{-1}$: $1/V_0 (\text{control}) = 0.096\,\text{min}/\mu\text{mol}$; $1/V_0 (+\text{inhibitor}) = 0.476\,\text{min}/\mu\text{mol}$

  • $1/[\text{S}] = 0.200\,\mu\text{M}^{-1}$: $1/V_0 (\text{control}) = 0.069\,\text{min}/\mu\text{mol}$; $1/V_0 (+\text{inhibitor}) = 0.345\,\text{min}/\mu\text{mol}$

  • $1/[\text{S}] = 0.100\,\mu\text{M}^{-1}$: $1/V_0 (\text{control}) = 0.044\,\text{min}/\mu\text{mol}$; $1/V_0 (+\text{inhibitor}) = 0.222\,\text{min}/\mu\text{mol}$

  • $1/[\text{S}] = 0.033\,\mu\text{M}^{-1}$: $1/V_0 (\text{control}) = 0.030\,\text{min}/\mu\text{mol}$; $1/V_0 (+\text{inhibitor}) = 0.147\,\text{min}/\mu\text{mol}$

  • $1/[\text{S}] = 0.011\,\mu\text{M}^{-1}$: $1/V_0 (\text{control}) = 0.025\,\text{min}/\mu\text{mol}$; $1/V_0 (+\text{inhibitor}) = 0.123\,\text{min}/\mu\text{mol}$

  • Linear Regression and Parameter Derivations:

  • Control (Uninhibited) Equation: $y = 0.224x + 0.0224$       $V_{\max} = \frac{1}{0.0224} = 44.6\,\mu\text{mol/min}$       $K_M = \frac{0.224}{0.0224} = 10.0\,\mu\text{M}$

  • Inhibited Equation: $y = 1.1084x + 0.1125$       $V_{\max}^{\text{app}} = \frac{1}{0.1125} = 8.89\,\mu\text{mol/min}$       $K_M^{\text{app}} = \frac{1.1084}{0.1125} = 9.85\,\mu\text{M}$

  • Inhibition Type Diagnosis: The lines converge directly at the x-axis ($K_M \approx K_M^{\text{app}} \approx 10\,\mu\text{M}$), demonstrating noncompetitive inhibition.

Irreversible Enzyme Inhibition and Drug Mechanisms

• Principles of Irreversible Inhibition:

  • Irreversible inhibitors associate covalently with catalytic residues or dissociate at an exceptionally slow rate, permanently disabling the enzyme.

  • They serve as critical pharmacological agents and experimental probes to identify essential catalytic residues in enzyme active sites.

• Transition-State Analogs (TSAs):

  • Formulated by Linus Pauling in 1948, the principle states that compounds chemically structured to resemble the transition state rather than the ground-state substrate function as extraordinarily potent, selective competitive inhibitors.

  • The effectiveness of a transition-state analog directly supports hypothesized chemical reaction geometries and verifies that maximal catalytic binding energy is concentrated at the transition state.

• Group-Specific Reagents:

  • Compounds that covalently modify specific amino acid side-chain functionalities without structurally mimicking an enzyme's substrate.

  • Diisopropylphosphofluoridate (DIPF): Selectively modifies reactive hydroxyl groups. In chymotrypsin, DIPF reacts exclusively with $\text{Ser } 195$ out of 28 total serine residues, permanently inactivating the enzyme.

  • DIPF also inactivates acetylcholinesterase, an essential enzyme for terminating cholinergic neurotransmission at synapses, by covalently labeling its active-site serine.

• Affinity Labels (Reactive Substrate Analogs):

  • Molecules that structurally resemble the natural substrate to target the enzyme active site, carrying an electrophilic functional group that forms a permanent covalent bond with an adjacent active-site residue.

  • Tosyl-L-phenylalanine chloromethyl ketone (TPCK): Acts as an affinity label for chymotrypsin. Its phenylalanine moiety directs binding to the chymotrypsin specificity pocket, where its reactive chloromethyl ketone moiety covalently alkylates an active-site imidazole nitrogen on $\text{His } 57$, irreversibly destroying peptidase activity.

• Mechanism-Based (Suicide) Inhibitors:

  • Modified substrates that bind to the active site and are initially converted by the normal catalytic machinery until a reactive chemical intermediate is generated.

  • This reactive intermediate immediately reacts with and covalently modifies active-site residues, permanently inactivating the enzyme.

  • Because the enzyme participates directly in its own chemical destruction, suicide inhibitors provide conclusive proof that the modified residue is essential for catalysis.

• Clinical Case Study: Penicillin as a Suicide Inhibitor:

  • Chemical Architecture: Penicillin contains a thiazolidine ring fused to a strained four-membered $\beta$-lactam ring, appended to a variable acyl side group ($\text{R}$) via an amide linkage.

  • Bacterial Cell Wall Target: Prevents the structural cross-linking of peptidoglycan, the rigid polysaccharide macromolecule shielding bacteria (such as Staphylococcus aureus) against internal osmotic lysis.

  • Biochemical Target: Glycopeptide transpeptidase catalyzes transpeptidation cross-links between neighboring glycan-peptide strands.

  • Structural Mimicry: Penicillin resembles the $\text{D-Ala-D-Ala}$ peptide terminus of the normal peptidoglycan substrate.

  • Inactivation Mechanism: Transpeptidase engages penicillin in its active site. An active-site serine hydroxyl attacks the carbonyl carbon of the strained $\beta$-lactam ring, opening the ring to generate a stable, irreversible penicilloyl-serine derivative that permanently blocks bacterial cell wall maturation.

• Biomedical Research Context: Christopher T. Walsh (1942–2023):

  • Established a career bridging chemistry, biology, and medicine, securing a joint appointment across the biology and chemistry departments at MIT in 1972, with subsequent leadership at Harvard Medical School and the Dana-Farber Cancer Institute.

  • Pioneered the mechanistic study of suicide inhibitors, antibiotic modes of action, bacterial drug resistance, and microbial natural-product biosynthesis.

  • Mentored over 250 graduate students and postdoctoral fellows with an emphasis on gender equity, published over 800 peer-reviewed papers, and authored three influential textbooks on enzymatic reaction mechanisms.

Structural and Chemical Mechanism of Chymotrypsin

• Proteolytic Function and Substrate Specificity:

  • Cellular protein turnover and dietary protein digestion require the degradation of polypeptides into free amino acids and small peptides via enzymatic hydrolysis:     $\text{Polypeptide} + \text{H}_2\text{O} \rightleftharpoons \text{Carboxylate component} + \text{Amine component}$

  • Chymotrypsin, a pancreatic serine protease, selectively cleaves peptide bonds on the carboxyl-terminal side of bulky, hydrophobic residues, including phenylalanine ($\text{Phe}$), tyrosine ($\text{Tyr}$), tryptophan ($\text{Trp}$), methionine ($\text{Met}$), and isoleucine ($\text{Ile}$).

• Kinetics of Hydrolysis and Pre-Steady-State Burst Phases:

  • Catalysis can be tracked spectrophotometrically using the chromogenic model substrate $N$-acetyl-L-phenylalanine $p$-nitrophenyl ester, which is cleaved to release yellow-colored $p$-nitrophenolate.

  • Biphasic Kinetic Profile:

  • Pre-Steady-State Burst Phase: An immediate, stoichiometric burst of $p$-nitrophenolate release occurs within milliseconds of mixing, producing exactly one mole of product per mole of active enzyme.

  • Steady-State Phase: A slower, constant rate of product generation corresponds to subsequent turnovers and obeys classical Michaelis–Menten kinetics.

• The Two-Step Catalytic Sequence:

  • Step 1 (Acylation): The catalytic nucleophile attacks the substrate, cleaving the peptide bond to liberate the amine/phenolate leaving group while forming a covalent acyl-enzyme intermediate at $\text{Ser } 195$. This rapid step accounts for the pre-steady-state burst.

  • Step 2 (Deacylation): Water enters the active site and hydrolyzes the acyl-enzyme intermediate, releasing the free carboxylic acid product and restoring the resting enzyme. Because deacylation is the slower, rate-limiting step, the overall turnover rate is dictated by deacylation velocity.

• The Catalytic Triad Architecture:

  • Chymotrypsin's active center contains a catalytic triad formed by three invariant residues:

  • Aspartate 102 ($\text{Asp } 102$)

  • Histidine 57 ($\text{His } 57$)

  • Serine 195 ($\text{Ser } 195$)

  • Hydrogen-Bonding Network:

  • The carboxylate group of $\text{Asp } 102$ forms a buried hydrogen bond with the $-\text{NH}$ group of the imidazole ring of $\text{His } 57$.

  • The opposing ring nitrogen of $\text{His } 57$ forms a hydrogen bond with the hydroxyl proton of $\text{Ser } 195$.

  • Functional Synergy:

  • $\text{Asp } 102$ precisely orients the imidazole ring of $\text{His } 57$ and increases its basicity through electrostatic stabilization.

  • When substrate binds, $\text{His } 57$ acts as a general base to extract the hydroxyl proton from $\text{Ser } 195$.

  • Deprotonation converts the neutral serine hydroxyl into an alkoxide ion, an exceptionally reactive nucleophile primed for attack on the substrate carbonyl carbon.

• Step-by-Step Peptide Hydrolysis Mechanism:

  • Step 1: Substrate Binding: The polypeptide binds to the enzyme, positioning the scissile peptide bond directly adjacent to $\text{Ser } 195$.

  • Step 2: Nucleophilic Attack and First Tetrahedral Intermediate Formation: The $\text{Ser } 195$ alkoxide oxygen attacks the carbonyl carbon of the scissile peptide bond. The planar carbonyl carbon transforms into an unstable tetrahedral intermediate bearing a formal negative charge on the carbonyl oxygen (the oxyanion).

  • Role of the Oxyanion Hole: The oxyanion is stabilized by hydrogen bonds donated from the backbone amide ($-\text{NH}-$) groups of Glycine 193 ($\text{Gly } 193$) and $\text{Ser } 195$. These interactions stabilize the transition state and lower the activation barrier.

  • Step 3: Tetrahedral Intermediate Collapse and Acyl-Enzyme Formation: The tetrahedral intermediate collapses to reform the carbon–oxygen double bond. $\text{His } 57$ acts as a general acid, donating a proton to the leaving amino group of the cleaved peptide chain.

  • Step 4: Amine Product Release: The newly protonated amine fragment dissociates from the active site, leaving the carboxyl terminal segment covalently linked to the enzyme as an ester (the acyl-enzyme intermediate).

  • Step 5: Water Binding and Activation: A water molecule enters the active site in place of the departed amine.

  • Step 6: Nucleophilic Attack by Hydroxide (Second Tetrahedral Intermediate): $\text{His } 57$ acts as a general base to extract a proton from the incoming water molecule. The resulting hydroxide ion attacks the carbonyl carbon of the acyl-enzyme intermediate, forming a second tetrahedral intermediate stabilized within the oxyanion hole.

  • Step 7: Intermediate Collapse and Ester Cleavage: The second tetrahedral intermediate collapses, reforming the carbonyl double bond. $\text{His } 57$ acts as a general acid to donate a proton back to the $\text{Ser } 195$ oxygen, severing the covalent ester bond to the substrate.

  • Step 8: Carboxylic Acid Product Release: The regenerated carboxylic acid product diffuses out of the active site, resetting the catalytic triad to its ground state for another round of turnover.

• Structural Basis of Substrate Recognition: The S1 Specificity Pocket:

  • High-resolution crystallographic studies show that chymotrypsin specificity is conferred by a deep, uncharged, hydrophobic cleft termed the $\text{S}_1$ pocket.

  • The pocket is lined by residues including Tryptophan 215 ($\text{Trp } 215$), Glycine 216 ($\text{Gly } 216$), Serine 189 ($\text{Ser } 189$), Cysteine 191 ($\text{Cys } 191$), Methionine 192 ($\text{Met } 192$), and Serine 217 ($\text{Ser } 217$).

  • This deep pocket accommodates large, hydrophobic aromatic rings (such as those in phenylalanine or tryptophan). Binding of the appropriate side chain within the $\text{S}_1$ pocket positions the adjacent peptide backbone bond into the active site for nucleophilic attack by $\text{Ser } 195$.